Meet us
18th Annual European Life Sciences CEO Forum
26. - 27. Februar
World ADC 2025
3. - 6. März
Anglo Nordic Life Science Conference
3. April
AACR Annual Meeting
25. - 30. April
Swiss Biotech Day 2025
5. - 6. Mai
Frühjahrskonferenz 2025 - Equity Forum
12. - 14. Mai
Bio International Convention
16. - 19. Juni
Current Presentations 2024
Upcoming Conferences 2024
Event | Date | Location |
---|---|---|
18th Annual European Life Sciences CEO Forum
|
26. - 27. Februar
|
Zürich
|
World ADC 2025
|
3. - 6. März
|
London
|
Kempen Life Science Conference
|
2. - 3. April
|
Amsterdam
|
Anglo Nordic Life Science Conference
|
3. April
|
London
|
AACR Annual Meeting
|
25. - 30. April
|
Chicago
|
Swiss Biotech Day 2025
|
5. - 6. Mai
|
Basel
|
Frühjahrskonferenz 2025 - Equity Forum
|
12. - 14. Mai
|
Frankfurt
|
Bio International Convention
|
16. - 19. Juni
|
Boston
|
Past Conferences 2024
Event | Date | Location | Download |
---|---|---|---|
WuXi Global Forum 2025, Executive Roundtable - Session II
|
14. Januar
|
San Francisco
| |
43rd Annual J.P. Morgan Healthcare Showcase Week and Conference
|
13. - 16. Januar
|
San Francisco
| |
ASH Annual Meeting and Exposition
|
7. - 10. Dezember
|
San Diego
| |
Deutsches Eigenkapitalforum
|
25. - 27. November
|
Frankfurt
| Download |
Annual World ADC San Diego
|
4. - 7. November
|
San Diego
| |
BIO-EUROPE
|
4. - 6. November
|
Stockholm
| |
HUPO World Congress
|
20. - 24. Oktober
|
Dresden
| |
R&D Webinar: Virtual KOL Event on Multiple Myeloma and New Clinical Data
|
15. Oktober
| ||
Festival of Biologics
|
15. - 17. Oktober
|
Basel
| |
16th Annual Healthcare Investor Conference
|
10. Oktober
|
London
| |
BioRN Annual Conference
|
9. Oktober
|
Heidelberg
| Download |
ADC Pharmacokinetics & Clinical Pharmacology Summit
|
8. - 10. Oktober
|
Boston
| |
21th International Myeloma Society Annual Meeting
|
25. - 28. September
|
Rio de Janeiro
| Download |
25th Conference on Global Summit on Analytical and Bioanalytical Techniques
|
24. - 25. Juli
|
Paris
| |
ADC Toxicity Summit Boston
|
23. - 25. Juli
|
Boston
|
Presentations are archived information about Heidelberg Pharma AG and were current at the time they were published. Archived information may have been replaced by more recent information published by the company in more recent presentations, press releases or elsewhere. The presentations and recordings may contain forward-looking statements based on management's beliefs as of the date of publication. Actual developments may differ materially from the information contained in the publications due to various factors.